BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24089457)

  • 1. Seropositivity to Helicobacter pylori and risk of pancreatic cancer.
    Yu G; Murphy G; Michel A; Weinstein SJ; Männistö S; Albanes D; Pawlita M; Stolzenberg-Solomon RZ
    Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2416-9. PubMed ID: 24089457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori seropositivity as a risk factor for pancreatic cancer.
    Stolzenberg-Solomon RZ; Blaser MJ; Limburg PJ; Perez-Perez G; Taylor PR; Virtamo J; Albanes D;
    J Natl Cancer Inst; 2001 Jun; 93(12):937-41. PubMed ID: 11416115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity.
    Kamangar F; Dawsey SM; Blaser MJ; Perez-Perez GI; Pietinen P; Newschaffer CJ; Abnet CC; Albanes D; Virtamo J; Taylor PR
    J Natl Cancer Inst; 2006 Oct; 98(20):1445-52. PubMed ID: 17047193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori infection, chronic corpus atrophic gastritis and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort: A nested case-control study.
    Huang J; Zagai U; Hallmans G; Nyrén O; Engstrand L; Stolzenberg-Solomon R; Duell EJ; Overvad K; Katzke VA; Kaaks R; Jenab M; Park JY; Murillo R; Trichopoulou A; Lagiou P; Bamia C; Bradbury KE; Riboli E; Aune D; Tsilidis KK; Capellá G; Agudo A; Krogh V; Palli D; Panico S; Weiderpass E; Tjønneland A; Olsen A; Martínez B; Redondo-Sanchez D; Chirlaque MD; Hm Peeters P; Regnér S; Lindkvist B; Naccarati A; Ardanaz E; Larrañaga N; Boutron-Ruault MC; Rebours V; Barré A; Bueno-de-Mesquita HB; Ye W
    Int J Cancer; 2017 Apr; 140(8):1727-1735. PubMed ID: 28032715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study.
    Hirabayashi M; Inoue M; Sawada N; Saito E; Abe SK; Hidaka A; Iwasaki M; Yamaji T; Shimazu T; Tsugane S
    Sci Rep; 2019 Apr; 9(1):6099. PubMed ID: 30988344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of Helicobacter pylori in relation to the risk for pancreatic cancer.
    Lindkvist B; Johansen D; Borgström A; Manjer J
    BMC Cancer; 2008 Nov; 8():321. PubMed ID: 18986545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori seropositivity and risk of lung cancer.
    Koshiol J; Flores R; Lam TK; Taylor PR; Weinstein SJ; Virtamo J; Albanes D; Perez-Perez G; Caporaso NE; Blaser MJ
    PLoS One; 2012; 7(2):e32106. PubMed ID: 22384154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study.
    Risch HA; Yu H; Lu L; Kidd MS
    J Natl Cancer Inst; 2010 Apr; 102(7):502-5. PubMed ID: 20181960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between Helicobacter pylori and pancreatic cancer risk: a meta-analysis.
    Schulte A; Pandeya N; Fawcett J; Fritschi L; Risch HA; Webb PM; Whiteman DC; Neale RE
    Cancer Causes Control; 2015 Jul; 26(7):1027-35. PubMed ID: 25951801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of helicobacter pylori infection and chronic atrophic gastritis with risk of colonic, pancreatic and gastric cancer: A ten-year follow-up of the ESTHER cohort study.
    Chen XZ; Schöttker B; Castro FA; Chen H; Zhang Y; Holleczek B; Brenner H
    Oncotarget; 2016 Mar; 7(13):17182-93. PubMed ID: 26958813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori seropositivities and risk of pancreatic carcinoma.
    Risch HA; Lu L; Kidd MS; Wang J; Zhang W; Ni Q; Gao YT; Yu H
    Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):172-8. PubMed ID: 24234587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Helicobacter pylori infection in pancreatic cancer].
    Gawin A; Wex T; Ławniczak M; Malfertheiner P; Starzyńska T
    Pol Merkur Lekarski; 2012 Feb; 32(188):103-7. PubMed ID: 22590913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Antiparietal Cell and Anti-Intrinsic Factor Antibodies With Risk of Gastric Cancer.
    Song M; Camargo MC; Katki HA; Weinstein SJ; Männistö S; Albanes D; Surcel HM; Rabkin CS
    JAMA Oncol; 2022 Feb; 8(2):268-274. PubMed ID: 34913949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori Seropositivity, ABO Blood Type, and Pancreatic Cancer Risk From 5 Prospective Cohorts.
    Lee AA; Wang QL; Kim J; Babic A; Zhang X; Perez K; Ng K; Nowak J; Rifai N; Sesso HD; Buring JE; Anderson GL; Wactawski-Wende J; Wallace R; Manson JE; Giovannucci EL; Stampfer MJ; Kraft P; Fuchs CS; Yuan C; Wolpin BM
    Clin Transl Gastroenterol; 2023 May; 14(5):e00573. PubMed ID: 36854058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori infection and development of pancreatic cancer.
    de Martel C; Llosa AE; Friedman GD; Vogelman JH; Orentreich N; Stolzenberg-Solomon RZ; Parsonnet J
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1188-94. PubMed ID: 18483341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum pepsinogen 1 and anti-Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males.
    Song M; Camargo MC; Weinstein SJ; Murphy G; Freedman ND; Koshiol J; Stolzenberg-Solomon RZ; Abnet CC; Männistö S; Albanes D; Rabkin CS
    Aliment Pharmacol Ther; 2018 Feb; 47(4):494-503. PubMed ID: 29243850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum pepsinogens and Helicobacter pylori in relation to the risk of esophageal squamous cell carcinoma in the alpha-tocopherol, beta-carotene cancer prevention study.
    Cook MB; Dawsey SM; Diaw L; Blaser MJ; Perez-Perez GI; Abnet CC; Taylor PR; Albanes D; Virtamo J; Kamangar F
    Cancer Epidemiol Biomarkers Prev; 2010 Aug; 19(8):1966-75. PubMed ID: 20647397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori blood biomarker for gastric cancer risk in East Asia.
    Cai H; Ye F; Michel A; Murphy G; Sasazuki S; Taylor PR; Qiao YL; Park SK; Yoo KY; Jee SH; Cho ER; Kim J; Chen SC; Abnet CC; Tsugane S; Cai Q; Shu XO; Zheng W; Pawlita M; Epplein M
    Int J Epidemiol; 2016 Jun; 45(3):774-81. PubMed ID: 27170766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxin-Associated Gene A-Negative Strains of Helicobacter pylori as a Potential Risk Factor of Pancreatic Cancer: A Meta-Analysis Based on Nested Case-Control Studies.
    Chen XZ; Wang R; Chen HN; Hu JK
    Pancreas; 2015 Nov; 44(8):1340-4. PubMed ID: 26390415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum gastrin and cholecystokinin are associated with subsequent development of gastric cancer in a prospective cohort of Finnish smokers.
    Murphy G; Abnet CC; Choo-Wosoba H; Vogtmann E; Weinstein SJ; Taylor PR; Männistö S; Albanes D; Dawsey SM; Rehfeld JF; Freedman ND
    Int J Epidemiol; 2017 Jun; 46(3):914-923. PubMed ID: 28369403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.